Skip to main content
VCbacked
Log inGet Started

Artax Biopharma

Cambridge, United States

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

$8.0M raised
Aug 2024
Convertible Note
BiopharmaBiotechnologyHealth CareTherapeutics

Top Investors

Eli LillyColumbus Venture PartnersSound BioventuresEli Lilly & Company FoundationAdvent Life Sciences

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Artax Biopharma

How much funding has Artax Biopharma raised?
Artax Biopharma has raised $8.0M in total funding. The most recent round was Convertible Note. The last funding was announced in August 2024.
Who are Artax Biopharma's investors?
Artax Biopharma's investors include Eli Lilly, Columbus Venture Partners, Sound Bioventures, Eli Lilly & Company Foundation, Advent Life Sciences.
Where is Artax Biopharma headquartered?
Artax Biopharma is headquartered in Cambridge, United States.
What does Artax Biopharma do?
Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
What stage is Artax Biopharma at?
Artax Biopharma is at the Convertible Note stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Artax Biopharma — Funding & Investors." VCBacked, August 6, 2024, https://www.vcbacked.co/company/artax-biopharma. Accessed July 1, 2026.
APA
VCBacked. (2024). Artax Biopharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/artax-biopharma
Wikipedia (cite web)
{{cite web |title=Artax Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/artax-biopharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M